KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Total Non-Current Liabilities (2022 - 2025)

QuidelOrtho's Total Non-Current Liabilities history spans 4 years, with the latest figure at $3.5 billion for Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities changed 0.14% year-over-year to $3.5 billion; the TTM value through Sep 2025 reached $3.5 billion, changed 0.14%, while the annual FY2024 figure was $3.4 billion, 2.59% down from the prior year.
  • Total Non-Current Liabilities for Q3 2025 was $3.5 billion at QuidelOrtho, up from -$3.1 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $3.8 billion in Q4 2022 and bottomed at -$3.2 billion in Q2 2024.
  • The 4-year median for Total Non-Current Liabilities is $3.4 billion (2023), against an average of $1.5 billion.
  • The largest annual shift saw Total Non-Current Liabilities fell 2.59% in 2024 before it grew 0.14% in 2025.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $3.8 billion in 2022, then dropped by 7.95% to $3.5 billion in 2023, then decreased by 2.59% to $3.4 billion in 2024, then grew by 3.43% to $3.5 billion in 2025.
  • Per Business Quant, the three most recent readings for QDEL's Total Non-Current Liabilities are $3.5 billion (Q3 2025), -$3.1 billion (Q1 2025), and $3.4 billion (Q4 2024).